A study examining birth outcomes following exposure to bictegravir during pregnancy found no significant safety concerns for fetal bictegravir exposure among a United States cohort. The authors emphasize the need for comparative data and continued surveillance of outcomes among infants exposed to bictegravir.
Citation:
Olivero R, Williams PL, Sawyer G, Yee LM, Patel K, Hernandez-Diaz S, Powis K, Paul M, Chadwick EG; Pediatric HIV/AIDS Cohort Study the HOPE study. Birth outcomes following bictegravir exposure during pregnancy. AIDS. 2024 Oct 15. doi: 10.1097/QAD.0000000000004041. Online ahead of print.
Article (subscription may be required)